Not exact matches
Prostate cancer is has a
genetic component but it has until now been impossible to understand
how aggressive the cancer might be Now a
new multi-national study has discovered the basis of a simple blood
test which can predict whether a man is susceptible to aggressive prostate cancer.
To build upon the encouraging early discoveries, Helmsley renewed and expanded its Crohn's funding for the Institute in 2013 to begin
new work with three major aims: 1) continue studies of individual genes to determine
how genetic differences between Crohn's patients and healthy individuals contribute to the disease; 2) evaluate promising small molecules in disease - relevant studies and prioritize insights from genetics to help develop novel therapeutics; and 3) begin basic experimentation in animal models with Crohn's disease to provide the data necessary to begin
testing new therapies in humans.
Every breeder must understand
how those
tests work and
how to apply them as we enter this brave
new world of
genetic testing.